2-(1-cyclopentylpiperidin-4-yl)ethanamine, 95.0%, 1g

3-BROMOPYRIDO[2,3-D]PYRIDAZIN-8(7H)-ONE, 95.0%, 1g

(2,3,6-Trimethoxyphenyl)boronic acid, 95.0%, 5g

8-Bromo-1,6-naphthyridine-2-carboxylic acid, 95.0%, 1g

2-Bromo-5-iodobenzonitrile, 95.0%, 1g

Diethyl 2-(2,4,6-trifluorophenyl)malonate, 95%, 1g

4-(3,4-Difluorophenyl)butanoic acid, 97%, 1g

tert-Butyl 2,9-diazaspiro[5.5]undecane-9-carboxylate hydrochloride, 95.0%, 250mg

2-Bromo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine, 98%, 100mg

tert-Butyl ((2S,3R)-2-methylpiperidin-3-yl)carbamate, 95%, 1g

Tripaflavina, mínimo 98,5 %, para bioquímica, 50 g, envase de vidrio

(3R,4S,5S,6R)-6-(hydroxymethyl)-2-methoxy-2-(4-methyl-3-((5-phenylthiophen-2-yl)methyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol, 98%, 5mg

4-[3-(Trifluoromethyl)phenyl]piperidin-4-ol hydrochloride, 97.0%, 100mg